Jeng et al. utilized cyclopamine, another SMO inhibitor, in a mouse hepatoma xenograft model and observed a reduction in tumor size, SHH mRNA, and GLI-1 mRNA levels [39]. This evidence concerns the gene GLI1 and neoplasm.